Lack of significant pharmacokinetic interaction between haloperidol and grapefruit juice

International Clinical Psychopharmacology

Volumn 14, Issue 2, 1999, Pages 113-118

  Yasui, N ^a   Kondo, T ^a   Suzuki, A ^a   Otani, K ^b   Mihara, K ^a   Furukori, H ^a   Kaneko, S ^a   Inoue, Y ^c  

^a HIROSAKI UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c Yoshitomi Pharmaceutical Industries Ltd   (Japan)

Author keywords

Bioavailability; CYP3A4; Grapefruit juice; Haloperidol; Reduced haloperidol

Indexed keywords

CYTOCHROME P450; ENZYME INHIBITOR; HALOPERIDOL; REDUCED HALOPERIDOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; FRUIT JUICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA;

EID: 0032985564     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199903000-00008     Document Type: Article

References (35)

1. Ameer B, Weintraub RA (1997) Drug interactions with grapefruit juice. Clin Pharmacokinet 33:103-121.
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders 4th edn. (DSM-IV). Washington DC: American Psychiatric Association.
3. Bech P, Kastrup M, Rafaelsen OJ (1986) Mini-compendium of rating scales for status of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand 73(Suppl 326):1-37.
4. Bock KW, Schrenk D, Forster A, Griese E-U, Morike K, Brockmeier D, Eichelbaum M (1994) The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics 4:209-228.
5. Daniel DG, Randolph C, Jaskiw G, Handel S, Williams T, Abi-dargham A, Shoaf S, Egan M, Elkashef A, Liboff S, Linnolia M (1994) Coadministration of fluvoxamine increases serum concentrations of haloperidol. J Clin Psychopharmacol 14:340-343.
6. Edward DJ, Bernier SM (1996) Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. Life Sci 59:1025-1030.
7. Eyles DW, McGrath JJ, Pond SM (1996) Formation of pyridinium species of haloperidol in human liver and brain. Psychopharmacology 125:214-219.
8. Fang J, Baker GB, Silverstone PH, Coutts RT (1997) Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol. Cell Mol Neurobiol 17:227-233.
9. Fuhr U, Klittich K, Staib AH (1993) Inhibitory effect of grapefruit juice and its bitter principal, naringenin on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 35:431-436.
10. Fukuda K, Ohta T, Oshima Y, Ohashi N, Yoshikawa M, Yamazoe Y (1997) Specific CYP3A4 inhibitors in grapefruit juice: Furocoumarin dimers as components of drug interaction. Pharamcogenetics 7:391-396.
11. Garzone PD, Kroboth PD (1989) Pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 16:337-364.
12. Guengerich FP, Kim DH (1990) In vitro inhibition of dihydropyridinc oxidation and aflatoxin BI activation in human liver microsomes by naringenin and other flavonoids. Cartinogenetics 11:2275-2279.
13. Hikida K, Inoue Y, Miyazaki T, Kojima N, Ohkura Y (1989) Determination of bromperidol in serum by automated column-switching high-performance liquid chromatography. J Chromatogr 495:227-234.
14. Holley FO, Magliozzi JR, Stanski DR, Lombrozo L, Hollister LE (1983) Haloperidol kinetics after oral and intravenous doses. Clin Pharmacol Ther 33:477-484.
15. Hukkinen SK, Varhe A, Olkkola KT, Neuvonen PJ (1995) Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin Pharmacol Ther 58:127-131.
16. Igarashi K, Kasuya F, Fukui M, Usuki E, Castagnoli Jr N (1995) Studies on the metabolism of haloperidol (HP): the role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP. Life Sci 26:2439-2446.
17. Jann MW, Saklad SR, Ereshefsky L, Richards AL, Harrington CA, Davis CM (1986) Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance. Psychopharmacology 90:468-470.
18. Jann MW, Lam YWF, Chang WH (1990) Reversible metabolism of haloperidol and reduced haloperidol in Chinese schizophrenic patients. Psychopharmacology 101:107-111.
19. Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, Watkins PB (1994). CYP3A gene expression in human gut epithelium. Pharmacogenetics 4:247-259.
20. Kupferschmidt HHT, Ha HR, Zileger WH, Meier PJ, Krähenbühl S (1995) Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 58:20-28.
21. Lindenmayer J-P, Bernstein-Hyman R, Grochowski S, Bark N (1995) Psychopathology of schizophrenia: initial validation of a 5-factor model. Psychopathology 28:22-31.
22. Lingjærde O, Ahlfors UG, Beeh P, Dencker SJ, Elgen K (1987) The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 76 (Suppl 334):11-100.
23. Lown KS, Kolars JC, Thummel KE, Barnett JL, Kunze KL, Wrighton SA, Watkins PB (1994) Interpatient heterogeneity in expression of CTP3A4 and CYP3A5 in small bowel: Lack of prediction by the erythromycin breath test. Drug Metab Dispos 22:947-955.
24. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W, WAtkins PB (1997) Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invent 99:2545-2553.
25. Miller DD, Kelly MW, Perry PJ, Coryell WH (1990) The influence of cigarette smoking on haloperidol pharamcokinetics. Biol Psychiatry 28:529-531.
26. Pan LP, Wijnant P, De Vriendt C, Rosseel MT, Belpaire FM (1997) Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol Br J Clin Pharmacol 44:557-564.
27. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons MK, He K, Lown KS, Woster PM, Rahman A, Thummel KE, Fisher JM, Hollenberg PF, Watkins PB (1997) Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents - Decreased enterocyte CYP3A4 concentration and mechanism-bused inactivation by furanocoumarins. Drug Metab Dispos 25:1228-1233.
28. Shimada T, Yamazaki H, Miura M, Inui Y, Guengerich FP (1994) Interindividual variation in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
29. Someya T, Shibazaki M, Noguchi T, Takahashi S, Inaba T (1992). Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbonyl reduction. J Clin Psychopharmacol 12:169-174.
30. Suzuki A, Otani K, Mihara K, Yasui N, Kaneko S, Inoue Y, Hayahsi K, (1997) Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients. Pharamcogenetics 7:415-418.
31. Tsang NM, Shader RI, Greenblatt DJ (1994) Metabolism of haloperidol: clinical implication and unanswered questions. J Clin Psychopharmacol 14:159-162.
32. Vanakoski J, Mattila MJ, Seppälä T (1996) Grapefruit juice does not enhance the effects of midazolam and triazolam in man. Eur J Clin Pharmacol 50:501-508.
33. Van Putten T, Marder SR, Mintz J, Poland RE (1992) Haloperidol plasma levels and clinical response: A therapeutic window relationship. Am 3 Psychiatry 149:500-505.
34. Wilkinson GR (1996) Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans. J Pharmacokinet Biopharmacol 24:475-490.
35. Yasui N, Kondo T, Otani K, Furukori H, Mihara K, Suzuki A, Kaneko S, Inoue Y. Effects of itraconazole on steady-state plasma concentrations of haloperidol and reduced metabolite in schizophrenic patients: in vivo evidence of involvement of CYP3A4 for haloperidol metabolism. J Clin Psychopharmacology (in press).